
Sayaji Hotels Bar License Suspended Pending FSSAI Order Revocation
Sayaji Hotels (Indore) Ltd has received an order from the District Excise Department, Indore, suspending its Hotel Bar (FL-3) Licence. This suspension is effective until the FSSAI suspension order is revoked or March 31, 2027, whichever comes first. This action follows an earlier order from the Food Safety and Standards Authority of India (FSSAI). However, the Hon'ble High Court of Madhya Pradesh, Indore Bench, has granted a stay on the FSSAI order. The company has informed the Excise Department about the High Court's stay. The exact financial impact is currently unascertainable, and further developments will be communicated.

Flex Foods Director Arvind Mahajan Completes Term
Flex Foods Ltd announced that Mr. Arvind Mahajan, an Independent Director, has completed his tenure. He was appointed on August 24, 2021, for a five-year term, which concludes on August 23, 2026. Consequently, he will cease to be an Independent Director of the company at the close of business hours on that date. The company has provided the necessary disclosures as per SEBI regulations.

Gujarat Intrux Board Approves Directors' Report, AGM Date, Dividend Record Date
Gujarat Intrux Ltd announced the outcome of its Board Meeting held on August 23, 2026. The board approved the Directors' Report for the financial year ended March 31, 2026, and fixed September 25, 2026, as the date for the 34th Annual General Meeting (AGM). A record date of September 1, 2026, was set for dividend payment and remote e-voting. The company also approved entering into a Power Purchase Agreement for a 1120 KW solar power project and accepted the resignation of its Company Secretary and Compliance Officer, appointing Mr. Kishor Madhubhai Kikani as the new officer.

Gujarat Themis Biosyn Amends Articles of Association
Gujarat Themis Biosyn Limited announced that its shareholders have approved an amendment to the company's Articles of Association via a special resolution passed through postal ballot on August 22, 2026. The amendment involves deleting specific wording from Article 13(1) Clause (c) related to the determination of share prices by a registered valuer. The revised clause now permits transactions for cash or consideration other than cash without the requirement of a valuation report.

Siddheswari Garments Ltd Board Meeting on Aug 29, 2026
Siddheswari Garments Ltd has announced that its Board of Directors will convene on August 29, 2026. The primary agenda item for this meeting is to consider and approve the notice for the Annual General Meeting (AGM) for the Financial Year 2025-2026. The meeting will also address any other business as permitted by the chair. This announcement is made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Eyantra Ventures Ltd Board Meeting on Aug 27 to Approve Q1 FY27 Results
Eyantra Ventures Ltd has announced that its Board of Directors will convene on August 27, 2026. The primary agenda item for this meeting is to consider and approve the Consolidated Un-audited Financial Results for the quarter ended June 30, 2026. Following this announcement, the company has also stated that the trading window will remain closed until 48 hours after the declaration of these financial results, extending the closure until August 29, 2026. This notice is in compliance with SEBI regulations.

IRB InvIT Fund Board Meeting to Consider Fund Raising
IRB InvIT Fund's Investment Manager, IRB Infrastructure Private Limited, will hold a board meeting on August 26, 2026. The meeting agenda includes considering and approving fund raising through various means such as issuing units, non-convertible debentures/securities, or debt. Approval from unitholders may be sought for the fund raise. Concurrently, the trading window for the Trust's units is closed until further notice, in accordance with the code of conduct for designated persons.

Urban Company Files Defamation Suit Against Kent RO
Urban Company Ltd has filed a defamation and disparagement suit against Kent RO Systems Limited in the Delhi High Court. The suit stems from Kent RO's advertising campaign, which Urban Company alleges made false and misleading claims about its NATIVE water purifiers' 2-year filter and service life, calling them a "marketing gimmick" and "unsafe". Following a hearing on August 12, 2026, Kent RO agreed to pull down the offending advertisements within 15 days and refrain from similar disparaging content. The court order was published on August 22, 2026. Other legal matters between the companies, including patent infringement and tortious interference suits, remain sub-judice.

Gujarat Themis Biosyn Amends Articles of Association
Gujarat Themis Biosyn Limited announced that its shareholders, through a special resolution passed at an Extraordinary General Meeting on August 22, 2026, have approved an amendment to the company's Articles of Association. Specifically, Clause 13(1)(c) has been amended by deleting the requirement for a valuation report from a registered valuer when determining the price of shares. The amended clause now broadly permits transactions for cash or consideration other than cash, irrespective of whether the parties involved are already mentioned in previous clauses.

Dharan Infra-EPC: Directors, KMP, Auditor Fail to Submit SEBI Info
Dharan Infra-EPC Limited (under CIRP) has informed the stock exchanges that despite repeated summons and reminders from SEBI, the suspended directors, key managerial personnel (KMP), and statutory auditor have failed to provide the pending information and records sought by SEBI within the stipulated timelines. The company is under investigation by SEBI, and this non-compliance could have further implications. The company will continue to update the stock exchanges on material developments.

Global Infratech & Finance Ltd Revised Annual Report 2026 Filed
Global Infratech & Finance Ltd has filed its Revised Annual Report for the financial year 2025-26. The company clarified that there are no changes to the figures in the Balance Sheet or Statement of Profit & Loss, with revisions limited to the numbering of Notes to Accounts. The report includes details on the Board of Directors, Key Managerial Personnel, Auditors, Bankers, and Registered Office. The 31st Annual General Meeting (AGM) is scheduled for September 16, 2026, to be held via Video Conferencing/Other Audio Visual Means. Key agenda items include the adoption of financial statements, re-appointment of a director, and approval for raising funds through Qualified Institutional Placement (QIP).

Donear Industries Ltd: TDS on Dividend Explained
Donear Industries Limited has issued a communication to its shareholders regarding the deduction of Tax Deducted at Source (TDS) on dividends. The company clarified that for resident individual shareholders, TDS will not be deducted if the total dividend does not exceed ₹10,000 in a financial year. For dividends exceeding this threshold, a 10% TDS applies if the PAN is updated. For non-resident shareholders, the TDS rate is 20% (plus surcharge and cess) or the applicable tax treaty rate, whichever is lower. The company also provided details on required documentation and forms for various shareholder categories to ensure correct TDS application.

Nyssa Corp Board to Consider Stake Sale in Proprietorship Firm
Nyssa Corporation Ltd has announced that its Board of Directors will convene on August 27, 2026. The primary agenda item for this meeting is to consider and, if deemed appropriate, approve the sale of the company's stake in a proprietorship firm. This disclosure is made in compliance with SEBI LODR Regulations, 2015, informing stakeholders about the upcoming strategic decision.

Jubilant Pharmova's USFDA nod for Spokane facility's Line 3
Jubilant Pharmova Limited announced that its subsidiary, Jubilant HollisterStier LLC (JHS), has received USFDA approval for commercial batch manufacturing on Line 3 of its contract manufacturing facility in Spokane, USA. This new Isolator-based fill and finish line will be used for the first product's commercial production. JHS is a key contract manufacturer of sterile injectables and ophthalmics, serving the pharmaceutical and biopharmaceutical industries. This approval signifies an expansion of JHS's capabilities and its role in supplying regulated markets.

Dhampure Speciality Sugars Ltd Revises FY26 Annual Report
Dhampure Speciality Sugars Ltd has issued a revised Annual Report for the Financial Year 2025-26. The revision pertains solely to product design/imagery on specific pages (3, 6, and 7) for presentation purposes. The company explicitly states there are no changes to the substantive or financial information within the report. This revised report, along with the Notice for the 34th Annual General Meeting, was submitted to the stock exchanges on August 20, 2026, in compliance with SEBI regulations. The company requests that the revised report be taken on record.








